FIELD: medicine, toxicology.
SUBSTANCE: invention proposes applying 15% aqueous solution of 1-methyl-5-[2'-(benzyldimethylammonio)ethyl]carbamoyl pyridinium-2-aldoxime dichloride that exceeds the 15% solution of dipiroxime (TMB-4, trimedoxime bromide) used in native medicinal practice by the curative effectiveness. Invention can be used in urgent treatment of acute poisoning with organophosphorus poisonous substances eliciting neuroparalytic effect.
EFFECT: enhanced effectiveness, valuable medicinal properties of agent.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT AND PREVENTION OF POISONING WITH PHOSPHORUS ORGANIC INSECTICIDES (POI) | 2008 |
|
RU2415668C2 |
METHOD FOR PREVENTING ACUTE EXPOSURE TO ORGANOPHOSPHATES | 2013 |
|
RU2555764C1 |
THERAPEUTIC APPLICATION OF DERIVED THIENYLCYCLOHEXYLAMINE | 1997 |
|
RU2183456C2 |
(1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
DIAGNOSTIC TECHNIQUE FOR SMALL-DOSE POISONING WITH ORGANOPHOSPHOROUS AGENTS | 2012 |
|
RU2484469C1 |
PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
REMEDY FOR TREATING THE CASES OF POISONING WITH M- CHOLINOLYTIC AGENTS | 0 |
|
SU1703110A1 |
0 |
|
SU558923A1 | |
RECOMBINANT PLASMID DNA OF PFUSE/SCFV47FC, INTENDED FOR PRODUCING SINGLE-CHAIN ANTIBODY FUSED WITH HUMAN IMMUNOGLOBULIN CONSTANT FRAGMENT INACTIVATING PARAOXONE PESTICIDE | 2019 |
|
RU2732835C1 |
MEDICINAL AGENT POSSESSING ANTITUMOR EFFECT | 2006 |
|
RU2314799C1 |
Authors
Dates
2005-01-10—Published
2003-06-24—Filed